TWO INJECTIVE ETFs ARE NOW PENDING SEC REVIEW.



Canary Capital. 21Shares. Both filed. Both under review.

Injective just joined the ETF conversation alongside BTC, ETH, SOL, XRP, LINK, AVAX, and HBAR.

Not a rumor. Not a "planned filing." Submitted and pending.

Native USDC from Circle. AI agent infrastructure live. CME-grade derivatives built into the protocol. Deflationary burns accelerating.

And now two separate asset managers independently decided that INJ deserves an ETF.

The protocols getting ETF filings aren't random. They're the ones with institutional-grade infrastructure that compliance teams can underwrite.

Injective built that infrastructure from day one. The ETFs are the validation.
INJ1,53%
BTC1,99%
ETH3,13%
SOL1,34%
post-image
post-image
post-image
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin